NCT05310513

Brief Summary

The purpose of this study is to explore the predictors of ICU admission of obstetric posterior reversible encephalopathy syndrome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
366

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 15, 2022

Completed
17 days until next milestone

Study Start

First participant enrolled

April 1, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 5, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2022

Completed
Last Updated

June 14, 2022

Status Verified

March 1, 2022

Enrollment Period

2 months

First QC Date

March 15, 2022

Last Update Submit

June 11, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • Blood Pressure(BP)

    blood pressure including systolic blood pressure (SBP), and diastolic blood pressure (DBP).

    The BP of patients was obtained immediately at the onset of symptoms.

  • severity of the edema

    The extent and severity of the edema observed in the lesion area were graded on a scale of 0-5 by evaluating FLAIR images.(0, normal; 1, limited cortical or subcortical white matter oedema; 2, white matter oedema \> cortical oedema, white matter oedema extending into deep white matter; 3, white matter oedema \> cortex oedema, oedema extending to the ventricular surface; 4, the involved regions substantially extend to the ventricular surface and are almost com- pletely confluent; 5, involved regions are fully confluent and con- tinuous, ventricular deformity due to the oedema).

    Cranial Imaging was examined immediately at the onset of symptoms, such as s headaches, visual changes, seizures, consciousness impairment.

  • pregnancy outcomes

    The rates of stillbirth and premature birth (gestation less than 37 weeks) in PRES patients.

    The pregnancy outcomes will record immediately when the patients deliver.

  • biochemical parameters

    The level of lactate dehydrogenase(LDH) will be measured,and LDH﹥380U/L means a worse outcome.

    Biochemical indicators were collected within 1 week of the hospital stay.

Study Arms (2)

ICU group

patients admitted to ICU with PRES.

Other: Whether the patient needs to be admitted to the ICU

Non-ICU group

patients not admitted to ICU with PRES.

Other: Whether the patient needs to be admitted to the ICU

Interventions

According to ICU admission or not, patients were grouped into ICU group and NOT-ICU group.

ICU groupNon-ICU group

Eligibility Criteria

Age16 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pregnant Women diagnosed with PRES

You may qualify if:

  • Pregnant Women were diagnosed of PRES.
  • all patients provided written informed consent

You may not qualify if:

  • patients combined with other neurological disorders
  • patients combined with mental illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Obstetrics and Gynecology, Key Laboratory for Major Obstetric Diseases of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University

Guangzhou, 510150, China

Location

MeSH Terms

Conditions

Posterior Leukoencephalopathy Syndrome

Condition Hierarchy (Ancestors)

Hypertensive EncephalopathyIntracranial HypertensionBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesLeukoencephalopathies

Study Officials

  • Dunjin Chen

    The Third Affiliated Hospital of Guangzhou Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Director of obstetrics

Study Record Dates

First Submitted

March 15, 2022

First Posted

April 5, 2022

Study Start

April 1, 2022

Primary Completion

May 31, 2022

Study Completion

May 31, 2022

Last Updated

June 14, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations